Login
$ORIC
$9.00 +$0.04 (0.5%) Close

Ownership

13F as of Q2 2026 · 103.7M shares outstanding

Who owns ORIC?

By type of holder
Institutions 100.0% Insiders 0.0% Everyone else 0.0%
Concentration Top 10 holders own 52.7%
Nextech Invest Ltd. 6.9% · BlackRock, Inc. 6.6%
Institutional ownership
100.0%
0 pts vs last qtr
Institutional holders
179
-3 vs last qtr
Net shares bought
+4.0M
by institutions in Q2 2026
New / sold out
30 / 33
positions opened vs closed

How is ownership changing?

Institutions, last 8 quarters

Biggest buyers in Q2 2026
  • D. E. Shaw & Co., Inc. +1.5M
  • AIHC Capital Management Ltd +1.4M

Sign up to see all 5.

Biggest sellers in Q2 2026
  • Pfizer Inc −4.4M
  • Paradigm Biocapital Advisors LP SOLD OUT −1.7M

Sign up to see all 5.

Who is planning to sell?

Notices of proposed sale, last 12 months
$4.83M
11 notices from 5 people
Shares covered
378.8K
0.37% of the company
Arranged in advance
75%
of the value is under a 10b5-1 plan
Under a 10b5-1 plan No plan
$0$1.5M$3.1MNovDec 2025: $496.6K without a planDecJan 2026: $160.8K under a 10b5-1 planJanFeb 2026: $702.0K without a planFebMarAprMayJunJul 2026: $160.8K under a 10b5-1 planJulAug 2026: $3.1M under a 10b5-1 planAugSepOct 2026: $211.5K under a 10b5-1 planOct
Largest proposed sellers
  • Dominic Piscitelli Officer $3.8M
  • Richard A, Heyman Director 10b5-1 $533K

Sign up to see all 5.

Every notice on Red Flags →

A Form 144 is notice of a planned sale, not the sale itself. What insiders actually sold is on Insider Transactions.

Is your stake being diluted?

Diluted share count, FY2021–FY2025
+131.3%
+23.32% a year
Each share's claim on the business
−56.8%
shrank without buying or selling a share
Spent on buybacks vs paid in stock
— vs $87.8M
over 5 fiscal years
Diluted shares, split-adjusted
36.8M62.7M88.7M2021: 38.0M shares'212022: 39.7M shares'222023: 51.5M shares'232024: 69.7M shares'242025: 87.8M shares'25
Buybacks Stock-based comp
$0$12.5M$25.0M2021 buybacks: $02021 stock comp: $12.9M'212022 buybacks: $02022 stock comp: $14.5M'222023 buybacks: $02023 stock comp: $15.2M'232024 buybacks: $02024 stock comp: $20.2M'242025 buybacks: $02025 stock comp: $25.0M'25

How patient are the owners?

Institutional shares by how long they've been held
5+ years34% 3–5 years16% 1–3 years36% Under 1 year14%
Quarterly turnover
13.6%
of institutional shares changed hands
Top 10 managers, median time held
4.5 years

Super Investors

Investment managers reporting ORIC on Form 13F
NI
Nextech Invest Ltd.
Shares
7.2M
% of company
6.91%
Change vs last qtr
Unchanged
Held since
2025
B
BlackRock, Inc.
Shares
6.8M
% of company
6.58%
Change vs last qtr
+839.4K (+14.0%)
Held since
≤2021

28 more super investors behind a free account

See every manager holding ORIC Pharmaceuticals, Inc., how their position has changed, and how long they've held it.

Sign up free

Institutional Funds

Mutual funds and ETFs reporting ORIC on Form N-PORT; together they hold 29.7% of the company
Position value
$35.4M
% of company
3.15%
% of the fund
0.33%
As of
June 30, 2026
VT
Position value
$31.6M
% of company
2.82%
% of the fund
0.00%
As of
June 30, 2026

23 more funds behind a free account

See every fund holding ORIC Pharmaceuticals, Inc. and how much of the fund the position is.

Sign up free

Insiders and 5%+ holders

From Forms 3/4/5 and Schedules 13D/G
SO
SR One Capital Management, LLC
5%+ holder13D · 4.8%
Shares
4.6M
% of company
4.45%
Change vs last qtr
—
Held since
—
CJ
Chacko Jacob
Insider
Shares
581.7K
% of company
0.56%
Change vs last qtr
—
Held since
—

5 more holders behind a free account

See every insider and 5%+ holder of ORIC Pharmaceuticals, Inc..

Sign up free

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support